International Stem Cell (ISCO) Assets (2010 - 2026)
International Stem Cell (ISCO) posted Assets of $5.06 million for Q2 2026, down 8.9% from $5.55 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell's Assets came in at $4.82 million, down 6.8% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- In prior years, International Stem Cell's Assets was $5.17 million in FY2024 (-4.0%), $5.39 million in FY2023 (+5.0%), $5.14 million in FY2022 (+3.8%) and $4.95 million in FY2021 (-6.4%).
- Quarterly Assets has run from a low of $4.82 million in Q4 2025 to a high of $5.79 million in Q2 2023 over five years.
- On a year-over-year basis, Assets increased in two of the last seven quarters, with an average decline of 3.1%.
- The strongest year-over-year quarter for Assets in the past five years was Q3 2023, with growth of 11.9%; the weakest was Q3 2021, with a decline of 15.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | International Stem Cell | 2.80 Mn | -1.17 Mn | 1.46 Mn | 5.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Mar 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.59 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 5.39 Mn |
| Sep 30, 2023 | 5.64 Mn |
| Jun 30, 2023 | 5.79 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 5.14 Mn |
| Sep 30, 2022 | 5.04 Mn |
| Jun 30, 2022 | 5.42 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 4.95 Mn |
| Sep 30, 2021 | 4.94 Mn |
| Jun 30, 2021 | 5.61 Mn |
API Access
International Stem Cell Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();